SciLucent, Inc.
Jeffrey Klein possesses extensive experience in nonclinical strategic product development and regulatory planning, currently serving as an Advisor for SciLucent, Inc. since May 2021, where responsibilities include developing regulatory strategies, conducting gap analyses, and managing interactions with regulatory authorities. Prior roles include Director of Toxicology and Dermatology at Sinclair Research and Director of Preclinical Research at EP TECHNOLOGIES LLC, showcasing expertise in toxicology studies, study design, and regulatory compliance. Klein's career spans various positions in leading pharmaceutical and research organizations, including Noven Pharmaceuticals, Ricerca Biosciences, Nucleonics, Inc., Purdue Pharma, and The Jackson Laboratory, with a strong foundation in animal sciences demonstrated through academic qualifications from Rutgers University and Penn State University, culminating in a Ph.D. in Animal Sciences.
This person is not in any offices
SciLucent, Inc.
SciLucent provides FDA-focused regulatory, clinical, nonclinical, CMC, quality, scientific, and management consulting services to healthcare product companies that develop, manufacture and/or market pharmaceuticals, biopharmaceuticals, medical devices, combination products, and dietary supplement ingredients. Since 1998 we have provided our clients with innovative strategies and exceptional quality work products intended to enhance product development, approval, and marketing presence.